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Summary
UV radiation is a major environmental risk factor for the development of melanoma by causing 
DNA damage and mutations. Resistance to UV damage is largely determined by the capacity of 
melanocytes to respond to UV injury by repairing mutagenic photolesions. The nucleotide 
excision repair (NER) pathway is the major mechanism by which cells correct UV photodamage. 
This multi-step process involves the basic steps of damage recognition, isolation, localized strand 
unwinding, assembly of a repair complex, excision of the damage-containing strand 3′ and 5′ to 
the photolesion, synthesis of a sequence-appropriate replacement strand and finally ligation to 
restore continuity of genomic DNA. In melanocytes, the efficiency of NER is regulated by several 
hormonal pathways including the melanocortin and endothelin signaling pathways. Elucidating 
molecular mechanisms by which melanocyte DNA repair is regulated offers the possibility of 
developing novel melanoma-preventive strategies to reduce UV mutagenesis, especially in UV-
sensitive melanoma-prone individuals.
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Melanoma
We and others have been interested in the mechanisms by which melanocytes regulate 
genomic stability through UV resistance and DNA repair because of the clear implications 
to melanoma, a malignancy whose incidence has been increasing for decades. Whereas one 
in every 1,500 Americans developed melanoma in the 1930’s, now almost one in fifty are 
affected by the disease)(Eggermont et al., 2014). According to the National Cancer 
Institute’s Surveillance, Epidemiology and End Results (SEER) program, over 75,000 
Americans were diagnosed with melanoma and the disease killed over 10,000 in 2016 alone. 
Though it accounts for less than 10% of all skin cancers, melanoma is responsible for over 
three quarters of all deaths by skin cancer (Shenenberger, 2012). It is likely that the 
increasing incidence of melanoma is multifactorial involving an aging population, better 
detection and awareness and more occupational and recreational UV exposure. Melanoma 
incidence peaks in the fifth decade of life, but it can afflict patients of any age, even 
children. In fact, it is the second most common cancer in young adults between the ages of 
15 and 29. Overall, it is estimated that over a million Americans alive today will be 
diagnosed with melanoma at some point in their lives (Geller et al., 2013). Although 
significant therapeutic advances have been made over the last decade by targeted therapy 
against the MAP kinase cascade and by immune checkpoint blockade, the majority of 
patients with advanced melanoma still die of their disease. Therefore, there is a great unmet 
need to understand the molecular mechanisms of melanoma susceptibility and to develop 
rational preventive strategies to reduce incidence of disease, particularly in individuals with 
an accumulation of identified risk factors.
Ultraviolet Radiation (UV) and its effects on DNA
Abundant epidemiologic and molecular data identify UV as a major environmental risk 
factor for melanoma (Berwick et al., 2014). Many melanomas derive from nevi on sun-
exposed areas of the body (Dodd et al., 2007; Sober, 1987; Valiukeviciene et al., 2007), 
melanoma incidence correlates with living in UV-rich climates (Lee and Scotto, 1993) and 
lifetime risk of melanoma increases with exposure to UV through tanning bed use 
(Schulman and Fisher, 2009; Weinstock and Fisher, 2010). A UV-melanoma link is 
strengthened by molecular studies that support the concept that UV exposure drives 
melanomagenesis. Melanoma carries a high somatic mutational burden and the 
overwhelming majority of mutations are characteristic “UV-signature” transitional mutations 
in adjacent pyrimidines (Hodis et al., 2012; Lawrence et al., 2013). Moreover, UV-signature 
mutational burden correlates with melanoma tumor progression (Shain et al., 2015), 
suggesting that UV drives many stages of melanoma development.
UV causes two main types of DNA injury. First, UV damages DNA through the production 
of free radicals and subsequent oxidative injury to nucleotide bases. Second, UV promotes 
covalent changes between pyrimidines directly through absorption of UV energy by cytosine 
and thymine. UV-induced DNA damage interferes with transcription, replication and 
genomic stability. Oxidative injury is recognized and repaired by the base excision repair 
pathway in which lesion-specific glycosylases recognize and remove damaged bases from 
the DNA backbone to generate apurinic sites that are subsequently filled in by polymerases 
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using the undamaged sister strand as a template. While oxidative lesions can be mutagenic 
and have been implicated in melanoma development and progression, we will focus our 
discussion on covalent UV photolesions and their repair since transitional pyrimidine 
mutations caused by covalent UV-induced pyrimidine photolesions represent the most 
common somatic mutations in melanoma (Hodis et al., 2012; Lawrence et al., 2013) and 
correlate with disease progression (Shain et al., 2015).
Through direct absorption of UV energy, the C5/C6 bond in pyrimidines (cytosines and 
thymines) is vulnerable to disruption. When this bond breaks between adjacent pyrimidines, 
abnormal bonds may form between the two bases to form cyclopyrimidine dimers (CPDs) or 
[6,4]-photoproducts (6-4PPs). Each of these covalent lesions distorts the double helix, 
interferes with transcription and replication and promotes base mispairing and mutagenesis. 
Since UV photodamage affects adjacent pyrimidines, its causality in mutagenesis can be 
determined by the presence of “UV signature” dipyrimidine transitional mutations (e.g. CC-
to-TT) throughout the genome and in cancer-relevant genes. Tumors that are driven by UV 
mutagenesis such as malignant melanoma of the skin, squamous cell carcinoma of the skin 
and basal cell carcinoma of the skin are rich in UV signature mutations (Wikonkal and 
Brash, 1999).
In addition to the initial CPD burden that occurs from UV photon-induced nucleotide 
changes in DNA, CPDs may continue to accumulate in melanocytes several hours after UV 
exposure ends. The mechanism responsible for “dark photodimer” formation was recently 
elucidated by Brash and colleagues and involves melanin as a redox energy transfer moiety. 
Thus, melanin acts as a substrate for UV-induced reactive oxygen and nitrogen species, and 
its chemiexcitation creates a quantum triplet state with the equivalent energy of a UV photon 
and the ability to break the C5/C6 bond in adjacent pyrimidines to yield CPDs (Premi et al., 
2015). Indeed, a large percentage of total UV-induced CPDs may develop through melanin 
chemiexcitation and delayed CPD formation. The discovery of dark photodimers is an 
important insight into melanocyte UV damage and resistance. Because many of the 
regulatory mechanisms that optimize melanocyte DNA repair may themselves be stimulated 
by UV (and therefore activated some time after UV exposure), they may be particularly 
relevant to the repair of dark photodimers in melanocytes.
Nucleotide Excision Repair (NER) and Xeroderma Pigmentosum (XP)
Nucleotide excision repair (NER) is the process by which cells repair helical-distorting DNA 
damage including CPDs and 6-4PPs. NER-targeted lesions, which promote physical 
deformities in the double helix, are detected either when they interfere with transcription 
(through stalling of RNA polymerase) which initates transcription-coupled NER (TC-NER), 
or when they are identified by damage sensing proteins that initiate global genomic NER 
(GG-NER). Although TC-NER and GG-NER differ in damage recognition, subsequent steps 
converge into one repair pathway (Fig 1). NER involves the action of over 30 proteins that 
process damage in a sequential series of reactions that can be summarized as follows: 1) 
DNA damage recognition, 2) recruitment of structural repair proteins, 3) DNA unwinding, 
4) assembly of a pre-incision complex, 5) 3′-5′ dual strand incision, 6) removal of a short 
oligonucleotide harboring the photodamage, 7) gap-filling using the sister strand as a 
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template and finally 8) DNA ligation (Scharer, 2013). NER is a damage-repairing 
mechanism of high fidelity that restores DNA to its pre-injured state and in this way is 
critical for resistance of melanocytes to UV-induced carcinogenesis.
The importance of NER in melanoma resistance is best illustrated by considering the natural 
history of xeroderma pigmentosum (XP), a rare UV hypersensitivity syndrome caused by 
homozygous defects in any of several genes associated with the NER pathway (XPA through 
XPG and DNA polymerase eta (POLH) (Giordano et al., 2016). XP typically manifests very 
early in life, the defining characteristics are sunlight-induced changes in cutaneous 
pigmentation and dry parchment-like skin. During childhood, pigment changes, 
telangiectasias and atrophy occur on UV-exposed skin. XP patients with defects in 
complementation groups A, B, D and G have hypersensitivity to UV with UV-induced 
inflammation (sunburns) occuring after minimal sun exposure, whereas groups C, E and 
variant do not. In the most serious cases, pre-malignant lesions such as actinic keratosis and 
fully malignant UV-induced cancers develop with great frequency. XP patients are up to 
2000 times more likely to develop melanoma and typically far earlier in life than melanomas 
develop in the general (non-XP) population (Bradford et al., 2011). As with sporadic 
melanomas, XP-associated melanomas frequently demonstrate “UV signature mutations” 
(Daya-Grosjean, 2008), clearly indicating the importance of UV in their causality and of 
NER in resistance against melanomas. Indeed, evidence is accumulating that inherited 
polymorphisms in NER genes that affect DNA repair are an important melanoma risk factor 
in the general population (Li et al., 2013; Xu et al., 2015). Please see the following excellent 
recent reviews for more detail about NER (DiGiovanna and Kraemer, 2012; Marteijn et al., 
2014; Sancar et al., 2004; Scharer, 2013; Wood, 2010).
Melanocyte interactions in the skin
Through cellular dendritic projections, epidermal melanocytes interact with up to thirty or 
more keratinocytes, fibroblasts and other skin cells (e.g. immune cells) in what has been 
termed the “epidermal unit” (Nordlund, 2007). There is abundant evidence to suggest a rich 
intercellular communication between cell types within the epidermal unit that regulates skin 
homeostasis and responses to UV injury (Cario-Andre et al., 2000; Gilchrest et al., 1996; 
Jimbow et al., 1991; Kawaguchi et al., 2001; Paus et al., 1999; Schiller et al., 2004; 
Scholzen et al., 2000; Virador et al., 2002). Keratinocytes, which make up the great majority 
of cells in the epidermis, influence melanocyte physiology by contact-dependent interactions 
and by contact-independent means via secretion of growth factors and regulators that act in a 
paracrine manner on melanocytes through specific ligand-receptor interactions (Imokawa et 
al., 1997; Imokawa et al., 1992; Jamal and Schneider, 2002; Kadekaro et al., 2005; Rousseau 
et al., 2007). Although NER can be augmented by cell-autonomous pathways such as 
autophagy (Qiang et al., 2016), we will focus our discussions on the regulation of 
melanocytic NER by the melanocortin and endothelin hormonal signaling pathways.
Melanocortin 1 receptor (MC1R)
The melanocortin 1 receptor (MC1R) is a Gs protein-coupled receptor located in the 
melanocyte extracellular membrane (recently reviewed (Wolf Horrell et al., 2016)). 
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Spanning the membrane seven times, the MC1R transmits ligand-receptor interactions to the 
cytoplasm through its association with adenylyl cyclase and production of the second 
messenger cAMP (Garcia-Borron et al., 2014). MC1R signaling regulates many aspects of 
melanocyte growth and differentiation. MC1R-directed increases in cAMP stimulate 
melanin production (Abdel-Malek et al., 2000; D'Orazio et al., 2006), increase cellular 
antioxidant levels (Kadekaro et al., 2003), protect melanocytes against apoptosis (McGill et 
al., 2002), stimulate growth (Suzuki et al., 1999) and augment the efficiency of NER (Abdel-
Malek et al., 2009; Bohm et al., 2005; Hauser et al., 2006; Jarrett et al., 2014; Jarrett et al., 
2015; Kadekaro et al., 2010; Song et al., 2009; Swope et al., 2014). Loss-of-function 
polymorphisms in MC1R are common, particularly in fair-skinned and sun-sensitive 
individuals (Valverde et al., 1995). Because MC1R stimulates the production of UV-
protective eumelanin in the skin, MC1R defects result in an under-melanized epidermis 
which allows more UV radiation to penetrate the skin (D'Orazio et al., 2006; Suzuki et al., 
1999). MC1R signaling defects also favor the production of pheomelanin, which blocks UV 
radiation much less effectively than eumelanin, promotes free radical formation (Hill et al., 
1997) and contributes to melanomagenesis (Mitra et al., 2012). A less eumelanized 
phenotype may have been selected in populations that migrated out of UV-rich equatorial 
regions to more polar climates in order to maximize UV-mediated vitamin D production and 
avoid rickets (Jablonski and Chaplin, 2013). These same MC1R polymorphisms, however, 
are carried by millions of individuals now living in UV-rich locations and clearly increase 
lifetime melanoma risk (Box et al., 2001; Kennedy et al., 2001; Pasquali et al., 2015; 
Valverde et al., 1996).
We and others have reported that MC1R defects also impair NER and melanocyte genomic 
stability. The integrity of the melanocyte genome is diminished when MC1R signaling is 
sub-optimal because NER is blunted (Hauser et al., 2006; Jarrett et al., 2014; Jarrett et al., 
2015; Swope et al., 2014). Thus, MC1R signaling problems result in an undermelanized 
epidermis permissive of UV entry and impaired melanocyte NER. MC1R-defective 
individuals are at higher risk of melanoma because their epidermal melanocytes accumulate 
more UV mutations over time. Indeed, Robles-Spinoze and coworkers recently reported that 
melanomas isolated from individuals harboring germline loss-of-function MC1R variants 
had 42% more somatic mutations than melanomas from MC1R-intact persons and that the 
overwhelming majority of these mutations were UV signature changes (Robles-Espinoza et 
al., 2016). Therefore, because MC1R signaling protects melanocytes from UV damage in a 
number of ways (Rouzaud et al., 2005; Scott et al., 2002), inherited MC1R defects clearly 
increase melanoma susceptibility (Kadekaro et al., 2010; Song et al., 2009).
MC1R (cAMP) signaling and NER
The melanocortin signaling axis promotes melanocyte genomic stability by positioning the 
cell to better cope with UV damage (Kadekaro et al., 2010). MC1R-mediated production of 
eumelanin is accomplished largely through transcriptional upregulation of pigment enzyme 
gene expression through CREB (cAMP responsive binding element) and MITF 
(microphthalmia) (Busca and Ballotti, 2000). As a result, there is a delay of several hours 
between MC1R-mediated cAMP increases and increased eumelanin production (Yamaguchi 
and Hearing, 2009). MC1R signaling also promotes expression of key DNA repair proteins 
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in a transcription-dependent manner. For example, MITF loss, which mimics blunted MC1R 
signaling, reduced the expression of many DNA repair factors including XPA, RPA, DNA 
ligase I, DNA polymerase delta (Pol δ) (Strub et al., 2011) and XPAB1 (April and Barsh, 
2006). These studies suggest that MC1R and MITF are needed to maintain optimal levels of 
a variety of DNA repair factors in melanocytes. In contrast, MC1R-enhanced DNA repair 
appears to involve both delayed and more immediate mechanisms, allowing melanocytes to 
augment their repair capacity in a much quicker and responsive manner after UV exposure 
than pigment up-regulation.
Elegant work from the Abdel-Malek lab first demonstrated that the melanocortin signaling 
axis controls melanocyte DNA repair (Kadekaro et al., 2005). Her group showed that UV 
exposure activated the DNA damage sensors ataxia telangiectasia mutated (ATM) and Rad3 
related (ATR), ATM, and DNA-PK (Kadekaro et al., 2012; Swope et al., 2014) and that 
melanocortin-enhanced DNA repair was influenced by increased levels of XPC and H2AX, 
potentially promoting the formation of DNA-repair complexes (Swope et al., 2014). Other 
components of the UV DNA damage repair response also are impacted by MC1R and 
include the NR4As superfamily of nuclear receptors which are recruited to sites of nuclear 
DNA damage together with XPC and DDB (Smith et al., 2008).
Our group discovered a molecular mechanism by which melanocytes require as little as 
15-30 minutes of cAMP stimulation to augment NER (Jarrett et al., 2014), linking MC1R/
cAMP signaling to NER through the ATR protein (Fig. 2) (Jarrett and D'Orazio, 2016). ATR 
is a non-dispensable Ser/Thr kinase in the same family as ATM and DNA-dependent protein 
kinase (DNA-PK). ATR is essential for cell survival; without it, cells undergo “mitotic 
catastrophe” during replication. ATR is important for damage signaling (Cimprich and 
Cortez, 2008), replication integrity (Cliby et al., 1998) and genomic maintenance and repair 
(Auclair et al., 2008). We determined that the critical molecular event linking MC1R 
signaling to enhanced NER in melanocytes is a non-canonical activation of ATR via 
phosphorylation by cAMP-dependent kinase (protein kinase A; PKA) (Jarrett et al., 2014). 
When cAMP levels are induced either through melanocortin signaling or pharmacologically 
via adenylyl cyclase activation (e.g. by forskolin) or phosphodiesterase inhibition (e.g. by 
rolipram), PKA is stimulated to phosphorylate ATR on Serine 435 (S435). However, instead 
of activating ATR to stop proliferation by Chk1 phosphorylation and cell cycle checkpoint 
blockade (ATR’s canonical role in cell damage responses), PKA-mediated phosphorylation 
of ATR on S435 promotes binding of ATR with the key NER factor XPA and together, ATR-
pS435 and XPA co-localize with UV photodamage in the nucleus (Jarrett et al., 2014). More 
recently, we identified A kinase anchoring protein 12 (AKAP12) as the critical molecular 
scaffold that facilitates PKA-mediated ATR phosphorylation on S435 (Jarrett et al., 2016). 
Like other AKAPs, AKAP12 is a bipartite protein able to bind the regulatory subunits of 
PKA through a conserved amphipathic protein interaction domain. It also binds relevant 
PKA-target proteins (in this case ATR) thereby scaffolding the PKA-ATR interaction. 
Mutating either AKAP12’s PKA binding sequence or AKAP12’s ATR binding region 
prevents PKA-mediated ATR phosphorylation and NER enhancement. As a result, there is 
persistence of UV photodamage in the genome and higher rates of UV mutagenesis (Jarrett 
et al., 2016).
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We have also gained insights into the mechanism by which the PKA-ATR-XPA pathway 
enhances NER. XPA is known to interact with a variety of NER factors, including TFIIH, 
RPA, XPC-RAD23B, DDB2, ERCC1-XPF and PCNA (Bunick et al., 2006; Gilljam et al., 
2012; Li et al., 1994; Nocentini et al., 1997; Park et al., 1995; Wakasugi et al., 2009; You et 
al., 2003). We measured XPA’s interactions with potential NER binding partners in UV-
irradiated melanocytes treated either with vehicle control or with forskolin to raise cAMP 
levels. Whereas XPA’s interactions with XPB, XPC and XPD were unaffected by cAMP 
stimulation, it’s binding to XPF, ERCC1 and RPA were increased as determined by co-
immunoprecipitation (Jarrett et al., 2016). Since XPF and ERCC1 function together to carry 
out the 5′ incision step of NER, we reasoned that cAMP stimulation may enhance the strand 
incision step 5′ to UV photodamage. To test this, we used conventional “bubble cutting” 
assays to test cAMP’s effect on 3′ and 5′ strand incision. Whereas, 3′ incision was 
unaffected by cAMP stimulation, forskolin promoted accelerated and enhanced 5′ strand 
incision, leading us to conclude that the MC1R-ATR-AKAP12-XPA DNA repair signaling 
axis augments NER through more efficient strand incision 5′ to sites of photodamage 
(Jarrett et al., 2016). Many more insights remain to be elucidated in this process, including 
mechanisms of cytoplasmic transport of AKAP12-ATR-pS435 complex, how the large 
complex is imported into the nucleus (AKAP12 and ATR both have molecular weights in the 
250 kDa range which excludes their nuclear entry by diffusion alone), how the complex 
associates with XPA once in the nucleus and how it targets UV photolesions.
Endothelin signaling and NER
Melanocyte growth and differentiation are regulated by many more signaling pathways than 
the melanocortin pathway (Swope and Abdel-Malek, 2016). One of the best characterized is 
the endothelin signaling axis. Endothelins were originally described as endothelial cell-
derived vasoactive peptides (Yanagisawa et al., 1988). There are three endothelins expressed 
in humans, each encoded by a separate gene (Inoue et al., 1989). Endothelins play a major 
role in melanocyte development and skin homeostasis. Endothelins stimulate melanocyte 
proliferation and pigment production (Yada et al., 1991) and are secreted by keratinocytes in 
a UV-dependent manner (Imokawa et al., 1992; Yohn et al., 1993). Indeed, signaling by 
endothelins through the endothelin B receptor (ETBR) is necessary for melanocyte 
development and defects lead to pigment phenotypes (Baynash et al., 1994; Hosoda et al., 
1994) due to defective neural crest maturation (Shin et al., 1999). ETBR signaling, which is 
mediated through intracellular calcium (Kang et al., 1998), regulates melanocyte dendricity 
(Hara et al., 1995), migration (Horikawa et al., 1995), E-cadherin expression (Jamal and 
Schneider, 2002), apoptosis (Eberle et al., 2002; Kadekaro et al., 2005), secretion of 
chemokines (Mangahas et al., 2005) and most recently, DNA repair (von Koschembahr et 
al., 2015).
Abdel-Malek and co-workers recently found that endothelin 1 (ET1), functioning through 
ETBR signaling, decreases the burden of UV photoproducts in irradiated melanocytes (von 
Koschembahr et al., 2015). Pretreating melanocytes with ET1 reduced UV photoproduct 
load over time, consistent with an augmentation of NER, but also at “time zero” 
immediately after UV exposure, raising the possibility that ET1 priming may protect cells 
from accumulating UV photodamage even before repair can occur. Intriguingly, ET1 
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treatment was independent of MC1R function, since it was not associated with cAMP 
changes and could protect melanocytes from UV damage even when cells expressed loss-of-
function MC1R isoforms (von Koschembahr et al., 2015). Our group independently 
confirmed that ET1 treatment does not impact cellular levels of ATR-pS435 (Jarrett et al., 
2015), suggesting that NER enhancement by endothelin signaling is distinct from that 
mediated by MC1R signaling and cAMP stimulation. Rather, ET1 activated JNK and p38 
signaling pathways and was calcium dependent since ET-1 mediated JNK activation and 
ATF2 phosphorylation were blocked by the Ca2+ chelator BAPTA. JNK signaling was 
critical to ET1-mediated melanocyte UV resistance since its inhibition blocked ET1-
mediated reductions in CPD’s and sensitized melanocytes to UV-mediated apoptosis. 
Mechanistically, the authors found that ET1 accelerated clearance of XPC, an NER factor 
involved in lesion recognition, from foci of photodamage. They interpreted these data to 
indicate that endothelin signaling improved XPC function to accelerate lesion recognition 
(von Koschembahr et al., 2015).
Melanoma prevention through enhanced DNA repair
Epidermal melanocytes are long-lived cells at risk of environmental UV exposure because of 
their position in the skin. While it is surprising that melanocytes wouldn’t always be 
optimally positioned to efficiently deal with UV DNA damage, we and others have 
documented that melanocytic NER is inducible by specific molecular pathways including 
melanocortin and endothelin signaling. Each of these pathways, when intact and activated by 
appropriate ligands (e.g. α-MSH and ET1, respectively) boosts melanocytic NER above 
baseline levels. This insight offers potential therapeutic opportunities for melanoma 
prevention by reducing UV mutagenic burden (Fig 3).
Regarding MC1R/cAMP signaling, there are two fundamental ways to achieve enhanced 
melanocyte NER in the skin. First, if MC1R signaling is intact, it may be possible to target 
melanocytes by taking advantage of the specificity of melanocortin interactions with MC1R. 
In the skin, most agree that MC1R expression is limited to melanocytes. Therefore 
melanocortin analogues (Abdel-Malek et al., 2009; Cho et al., 2005; Ruwe et al., 2009; Yang 
et al., 2009) would be expected to target melanocytes without much off-target effect. While 
targeting approaches that limit cAMP induction to melanocytes is important because of the 
potential for off-target effects, this approach may not benefit individuals harboring loss-of-
function mutations in MC1R since signaling through their MC1Rs is blunted. Since these 
persons are among those of highest risk of melanoma in the general population (Kennedy et 
al., 2001; Valverde et al., 1996), a broader therapeutic strategy may be needed such as 
topical application of agents that increase cAMP levels in skin cells either through adenylyl 
cyclase activation or phosphodiesterase inhibition both of which have been validated in an 
Mc1r-defective UV-sensitive animal model of the fair-skinned human with respect to 
pigmentation (Amaro-Ortiz et al., 2013; D'Orazio et al., 2006; Khaled et al., 2010; Spry et 
al., 2009). Indeed, we have already shown in proof-of-principle pre-clinical experiments that 
topical application of forskolin enhanced clearance of UV photodamage in the skin (Jarrett 
et al., 2014).
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Another potential strategy for enhancing melanocytic NER, even in MC1R-defective 
individuals, may be to take advantage of the endothelin signaling axis. If therapies can be 
developed to target the endothelin pathway in epidermal melanocytes, NER may be 
enhanced irrespective of MC1R status. Clearly much more research is needed to understand 
the feasibility of each of these different therapeutic strategies, but the key concept that has 
emerged from these studies is that it may be possible to reduce UV damage to epidermal 
melanocytes and lessen melanoma risk by augmenting melanocyte genomic stability by 
optimizing NER.
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Fig. 1. Overview of nucleotide excision repair (NER)
UV photodamage is repaired by the NER pathway, which can be subdivided into global 
genome NER (GG-NER) and transcription-coupled NER (TC-NER). GG-NER occurs 
anywhere in the genome and is initiated by recognition of a distorted double helix, as occurs 
with UV photoproduct formation. In GG-NER, XPC, stabilized in complex with RAD23B 
and enabled to recognize CPDs by UV-damage-binding protein 2 (DDB2), identifies sites of 
damage, binding to the strand opposite the photolesion. In contrast, TC-NER is initiated in 
actively transcribed genes by stalling of RNA polymerase at the photolesion and involves the 
CSA, CSB and XAB2 cofactors. TC-NER, which probably accounts for no more than 10% 
of total NER, differs from GG-NER only through initial lesion recognition; the pathways 
merge downstream into a common NER mechanism beginning with pre-incision complex 
formation. In both GG-NER and TC-NER, TFIIH (a multi-complex protein containing the 
XPB and XPD helicases as well as 8 other subunits) is recruited to the site of damage. Using 
its XPB and XPD helicase components, TFIIH unwinds the DNA around the photolesion, 
initiating strand separation to enable the recruitment of other NER factors to form a “pre-
incision complex”. XPA, replication protein A (RPA), XPG, XPF and ERCC1 are each 
recruited to the complex, and at some point, initiation factors exit the region. Next, there is 
incision of the photolesion-containing strand some distance away from the DNA lesion. 
Strand incision is accomplished by XPF-ERCC1 working in complex to cleave the strand 5′ 
to the damage and by XPG 3′ to the damage. Evidence suggests that 5′ strand cleavage 
may actually occur before 3′ strand cleavage and in fact, DNA polymerase may begin filling 
in the gap from the 5′ side before the 3′ incision step. After 5′ and 3′ strand incision, a 
24-32mer oligonucleotide harboring the photolesion is generated that is removed (associated 
with TFIIH) from chromatin. The resultant gap is then filled in by DNA polymerases 
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together with PCNA, RFC and RPA using the undamaged sister strand to ensure fidelity of 
repair. Finally DNA ligation is achieved by DNA ligases I, III or XRCC1 to complete the 
process.
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Fig. 2. MC1R-mediated NER augmentation by the AKAP12-ATR-XPA axis
In melanocytes, enhancement of NER by cAMP is dependent on a damage-dependent 
cytoplasmic interaction between ATR and PKA, scaffolded by AKAP12. If cAMP levels 
have been stimulated either through MC1R-agonist interactions or pharmacologically, 
cAMP-dependent protein kinase (PKA) is activated. Like other A-kinase anchoring proteins, 
AKAP12 is a bipartite molecule that brings together PKA with its appropriate 
phosphorylation targets (in this case ATR). PKA then phosphorylates ATR on S435 to 
stimulate ATR’s interaction with XPA in the nucleus. Traffic of ATR-pS435 to the nucleus 
happens in the context of AKAP12 binding, and nuclear translocation of the AKAP12-ATR-
p435S complex is dependent on ATR’s phosphorylation of AKAP12 on the S732 residue. 
Together, ATR, AKAP12 and XPA localize to sites of UV photodamage in chromatin. 
cAMP accelerates NER by enhancing 5′ strand incision, a molecular event mediated by 
XPF-ERCC1. In this way, MC1R/cAMP signaling improves cellular ability to repair UV 
photodamage, resulting in lowered rates of UV mutagenesis and improved genomic stability.
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Fig. 3. UV-preventive strategies based on enhancing NER in melanocytes
Discovering that melanocyte NER can be regulated by the MC1R/cAMP and ETBR/Ca++ 
signaling pathways introduces the opportunity to reduce UV-mediated mutagenesis and 
carcinogenesis by enhancing melanocyte genomic stability to reduce UV mutational burden 
over time. Potential approaches would include targeting the MC1R and ETBR signaling 
pathways by agonistic mimics, inhibitors of antagonist ligands and downstream induction of 
intracellular signaling mediators.
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